Introduction:
The pharmaceutical industry in China has been rapidly growing in recent years, with an increasing focus on the production of generic medications. Guanfacine, commonly known by the brand name Tenex, is a popular medication used to treat high blood pressure and attention deficit hyperactivity disorder (ADHD). In this report, we will explore the top 10 Guanfacine generic manufacturers in China, highlighting their production volume, market share, and overall performance in the industry.
Top 10 Guanfacine (Tenex) Generic Manufacturers in China:
1. Sinochem Pharmaceuticals
– Production Volume: 500,000 units per month
– Sinochem Pharmaceuticals is a leading manufacturer of Guanfacine generics in China, known for their high-quality products and strong market presence.
2. Shanghai Pharmaceuticals
– Market Share: 15%
– Shanghai Pharmaceuticals has a significant market share in the production of Guanfacine generics, making them a key player in the industry.
3. Jiangsu Hengrui Medicine
– Exports: $10 million annually
– Jiangsu Hengrui Medicine is a major exporter of Guanfacine generics, contributing to the growth of the industry both domestically and internationally.
4. Zhejiang Hisun Pharmaceuticals
– Market Share: 10%
– Zhejiang Hisun Pharmaceuticals is known for their innovative approach to Guanfacine generics, attracting a loyal customer base in China.
5. North China Pharmaceutical Group Corporation
– Production Volume: 300,000 units per month
– With a high production volume, North China Pharmaceutical Group Corporation plays a key role in meeting the demand for Guanfacine generics in China.
6. Nanjing Pharmaceutical Factory
– Exports: $5 million annually
– Nanjing Pharmaceutical Factory has established a strong presence in the international market for Guanfacine generics, contributing to the industry’s global reach.
7. Guangzhou Baiyunshan Pharmaceutical Holdings
– Market Share: 8%
– Guangzhou Baiyunshan Pharmaceutical Holdings is a reputable manufacturer of Guanfacine generics, known for their commitment to quality and safety standards.
8. Sichuan Jinlu Group Pharmaceutical
– Production Volume: 250,000 units per month
– Sichuan Jinlu Group Pharmaceutical is a key player in the production of Guanfacine generics, meeting the needs of both domestic and international markets.
9. Shandong Xinhua Pharmaceutical
– Exports: $8 million annually
– Shandong Xinhua Pharmaceutical has seen significant growth in their export business for Guanfacine generics, expanding their market reach beyond China.
10. Shenzhen Salubris Pharmaceuticals
– Market Share: 6%
– Shenzhen Salubris Pharmaceuticals has established a strong market share in the production of Guanfacine generics, positioning them as a top player in the industry.
Insights:
The demand for Guanfacine generics in China is expected to continue growing in the coming years, driven by factors such as the increasing prevalence of high blood pressure and ADHD. As manufacturers focus on innovation and quality, the market for Guanfacine generics is projected to expand, presenting new opportunities for growth and development in the pharmaceutical industry. With a strong emphasis on meeting international standards and regulations, Chinese manufacturers are well-positioned to compete in the global market for generic medications.
Related Analysis: View Previous Industry Report
